Patient stratification for treatment decisions and tumour-normal pair or liquid biopsy specimen profiling for patient-unique therapies
NGS-based molecular profiling with clinical-relevant turnaround times for precision oncology brings treatment decisions & personalized cancer treatment manufacturing within reach. For clinical profiling, a clinical relevant turnaround time is key. We have dedicated solutions for low-input and FFPE-tissues.
Applications
Combination of genetic and transcriptomic characterization of paired tumour-normal specimens or blood allows for a quick prediction and selection of neoantigens for personal cancer vaccine development and adoptive cell therapies. In addition, we offer solutions to verify your viral vector-, CAR-T or TCR-T libraries.
Patient stratification for treatment decisions with dedicated biomarkers, comprehensive cancer panels and stratification at genetic (including WGS), transcriptomic, and epigenetic level are at your disposal.
How can I help you?
Let's get the conversation started for your next NGS project
Please either fill in below or email us directly at oncology@genomescan.nl
and we will get in touch with you to discuss your requirements
